Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice

Pharmazie

Volumn 62, Issue 6, 2007, Pages 439-444

  Zhu, Yu ^a   Xie, Liping ^a   Chen, Guang ^a   Wang, Hongzhong ^a   Zhang, Rongqing ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ORIDONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; STAINING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; DITERPENES; DITERPENES, KAURANE; FEMALE; HT29 CELLS; HUMANS; INDICATORS AND REAGENTS; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 34250847036     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.6.6691     Document Type: Article

References (30)

1. Chen S, Gao J, Halicka D, Huang X, Traganos F, Darzynkiewicz Z (2005) The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. Intern J Onco 26: 579-588.
2. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (pt2): 233-249.
3. Fujita E, Nagao Y, Kaneko K, Nakazawa S, Kuroda H (1976a) Terpenoids. XXXVI. Biological and physiological activity. I. The antitumor and anti-bacterial activity of the Isodon diterpenoids. Chem Pharm Bull. 24: 2118-2127.
4. Fujita E, Nagao Y, Node M, Kaneko K, Nakazawa S, Kuroda H (1976b) Antitumor activity of the isodon diterpenoids: structural requirements for the activity. Experientia 32: 203-206.
5. Fujita T, Takeda Y, Sun H D, Minami Y, Marunaka T, Takeda S. (1988) Cytotoxic and antitumor activities of Rabdosia diterpenoids. Planta Med 54: 414-417.
6. Green D R, Reed J C (1998) Mitochondria and apoptosis. Science 281: 1309-1312.
7. Guo J J, Pan X L, Feng C W, Zou J H (2002) Study on reversal effects of oridonin on multidrug resistant cell line K562/A02. Shanghai Med J 25: 43-45.
8. Han Q B, Li M L, Li S H, Mou Y K, Lin Z W, Sun H D (2003) Ent-kaurane diterpenoids from Isodon rubescens var. lushanensis. Chem Pharm Bull 51: 790-793.
9. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776.
10. Hirsch T, Marzo I, Kroemer G (1997) Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep 17: 67-76.
11. Huang KC (1992) Pharmacopedia of Chinese Herbal Medicine. Cleveland: CRC Press, pp. 290-291.
12. Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H, Koeffler HP (2003) Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Intern J Onco 23: 1187-1193.
13. Johnson LV, Walsh ML, Chen LB (1980) Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci (USA) 77: 990-994.
14. Kubo I, Taniguchi M, Satomura Y, Kubota T (1974) Antibacterial activity and chemical structure of diterpenoids. Agri Bio Chem 38: 1261-1262.
15. Liu JJ, Lu HL, Chen LX, Lv DJ, Tong DY, Qu JH (2003) Anti-proliferation effect of oridonin on leukemic NB4 cells. Chin Pract Chin Mod Med 3: 2009-2010.
16. Liu YQ, You S, Zhang CL, Tashiro SI, Onodera S, Ikejima T (2005) Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells. Biol Pharm Bull 28: 461-467.
17. Moore, MA, Tsuda H (1998) Chronically elevated proliferation as a risk factor for neoplasia. Europ J Can Prevent 7: 353-385.
18. Mori H, Sugie S, Yoshimi N, Hara A, Tanaka T (1999) Control of cell proliferation in cancer prevention. Mutation Res 428: 291-298.
19. Murray AW (2004) Recycling the cell cycle: Cyclins revisited. Cell 116: 221-234.
20. Norbury CJ, Zhivotovsky B (2004) DNA damage-induced apoptosis. Oncogene 23: 2797-2808.
21. Nurse PM (2002) Cyclin dependent kinases and cell cycle control. Biosci Rep 22: 487-499.
22. Panaro NJ, Popescu NC, Harris SR, Thorgeirsson UP (1999) Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells. Br J Cancer 80: 1905-1911.
23. Pines J (1995) Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 308: 697-711.
24. Ren KK, Wang HZ, Xie LP, Chen DW, Liu X, Sun J, Nie YC, Zhang RQ (2006) The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharm 103: 176-180.
25. Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, Di FG, Macaluso M, Bazan V (2005) Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy. J Cell Phys 204: 742-749.
26. Wang J, Liu QY, Hu HY, Ye QX, Zhang Y, Zhang TM (2001) Oridonin induces apoptosis in human leukemia HL-60 cells. Chin Pharm Bull 17: 402-404.
27. Wu KM, Zhang TM, Wang QD, Hua HY, Qi JY, Zhang Y (1994) Effect of oridonin on the activity of tumor cell sodium pump. Cancer Res Prevent and Treatm 21: 208-209.
28. Xue HW, Pan XL, Yang SJ (2005) Effect of rubescensine A on apoptosis and bcl-2, p53, fas/apo-1 and c-myc expression in GBC-SD cells. J Shandong Univ (Health Sciences) 43: 336-339.
29. Yan JT, Yang SL, Gong YO, Ding LP, Song AY (2005) Effect of oridonin on DNA damage in the mammalian cells. HeNan J Onco 18: 83-84.
30. Zhang CL, Wu LJ, Zuo HJ, Tashiro SI, Onodera S, Ikejima T (2004) Oridonin-induced A375-S2 cell apoptosis through mitochondrial pathway. Chin Trad Herb Drugs 35: 423-426.